FOFederica Olmati

Federica Olmati

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Federica Olmati has a total of 22 co-authors. Here are the top co-authors by number of shared publications:

  • Ambra Nicolai

    Pulmonology Division, Department of Public Health and Infectious Diseases, Policlinico Umberto I, “Sapienza” University of Rome, Rome, Italy

    5 shared publications
  • Antonio Fabozzi

    Department of Public Health and Infectious Diseases, Pulmonology Unit, Policlinico Umberto I, “Sapienza” University of Rome, Rome, Italy

    5 shared publications
  • Matteo Bonini

    Pulmonology Unit, Department of Public Health and Infectious Diseases, Policlinico Umberto I, “Sapienza” University of Rome, 00185 Rome, Italy

    5 shared publications
  • Paolo Palange

    Pulmonology Unit, Department of Public Health and Infectious Diseases, Policlinico Umberto I, “Sapienza” University of Rome, 00185 Rome, Italy

    5 shared publications
  • Arianna Sanna

    Pulmonology Division, Department of Public Health and Infectious Diseases, Policlinico Umberto I, “Sapienza” University of Rome, Rome, Italy

    4 shared publications
  • Alessia Steffanina

    Pulmonology Division, Department of Public Health and Infectious Diseases, Policlinico Umberto I, “Sapienza” University of Rome, Rome, Italy

    3 shared publications

Latest Publications

  • How obstructive sleep apnea differs in COPD and asthma: insights from a clinical and functional study

    by Antonio Fabozzi, Alessia Steffanina, Ambra Nicolai, Maria D’ANdria, Alessandro Porcella, Federica Olmati, Arianna Sanna, Matteo Bonini, Paolo Palange

  • Open Access

    Rethinking Long-Term Follow-Up of CPAP Therapy in Obstructive Sleep Apnea: Toward Personalized and Integrated Care

    by Antonio Fabozzi, Francesca Romana Manfredi, Noemi Ascarelli, Laura Melis, Ilaria Domenica Piscopo, Federica Olmati, Ambra Nicolai, Arianna Sanna, Caterina Antonaglia, Alessia Steffanina, et al.

    Background: Although the diagnostic and treatment pathway for Obstructive Sleep Apnea (OSA) is well established, long-term management is still not standardized. Methods: We conducted a narrative review of studies published between 2000 and 2026 in PubMed/MEDLINE. Results: Continuous Positive Airway Pressure (CPAP) adherence and healthcare resource allocation remain the real critical issue of long-term management for OSA patients. Early proactive interventions like phone calls and early medical visits may be particularly valuable for improving CPAP nightly usage. Telemedicine, educated and trained home-care providers or primary care can lead to improved adherence, long-term monitoring and earlier identification of treatment-related issues. Patient-reported outcomes, comorbidities, endotypes, and phenotypic stratification should be integrated into follow-up management. Conclusions: OSA long-term care should shift from a device-centered approach toward a personalized, patient-centered model with the integration of multidimensional risk stratification, multidisciplinary care, telemedicine and primary care support.


  • Open Access

    Optimizing CPAP Adherence in Obstructive Sleep Apnea: A Narrative Review of Practical Strategies for Everyday Clinical Care

    by Caterina Antonaglia, Antonio Fabozzi, Alessia Steffanina, Sara Soave, Paola Confalonieri, Ambra Nicolai, Federica Olmati, Arianna Sanna, Nahuan Pena, Barbara Ruaro, et al.

    Background: Continuous positive airway pressure (CPAP) is the primary treatment for obstructive sleep apnea (OSA). Despite improvements in CPAP technology and management, adherence to therapy remains one of the main challenges to be addressed. Methods: We conducted a narrative review through PubMed (1995–2026). Studies were selected by clinical relevance, methodological quality and expert consensus. Results: OSA treatment outcomes are poor when CPAP adherence is defined as four hours per night. The first step in improving adherence is active patient involvement. This involves explaining what OSA is, its consequences, what PAP therapy is, and its potential benefits. The choice of the right mask is the first personalized step in CPAP adherence. OSA phenotype and endotype traits may help personalize treatment in selected patients, although their role in predicting CPAP adherence needs to be studied in greater depth. Problems during the first night and the first month are the main predictors of future adherence. Strategies such as cognitive behavioral therapy or motivational enhancement can improve adherence, especially during the initial period. Long-term adherence can be predicted from the initial period and maintained through scheduled follow-up. Group meetings, telephone calls and telemedicine interactions are also a valid way of improving adherence. Conclusions: Patients should initially be educated about how their symptoms are related to sleep apnea and how CPAP treatment could resolve them. The key to improving CPAP adherence is involving patients in personalized treatment with scheduled follow-up, particularly during the initial treatment period.


  • Open Access

    Optimizing CPAP Adherence in Obstructive Sleep Apnea: Practical Strategies for Everyday Clinical Care

    by Caterina Antonaglia, Antonio Fabozzi, Alessia Steffanina, Sara Soave, Paola Confalonieri, Ambra Nicolai, Federica Olmati, Arianna Sanna, Nahaun Pena, Barbara Ruaro, et al.

    Background: Continuous positive airway pressure (CPAP) is the primary treatment for Obstructive Sleep Apnea (OSA). Despite improvements in CPAP technology and management, adherence to therapy remains one of the main issues to be fixed. Methods: We conducted a narrative review through PubMed (1995-2025). Studies were selected by clinical relevance, methodological quality and expert consensus. Results: OSA treatment outcomes are poor when CPAP adherence is defined as four hours per night. The first step in improving adherence is active patient involvement. This involves explaining what OSA is, its consequences, what PAP therapy is, and its potential benefits. The right mask should be chosen for each patient; a nasal mask should be the first choice according to the Starling resistor model. OSA endotype and phenotype traits could be used to predict adherence, guide adjunct therapy, or suggest titration. Problems during the first night and the first month are the main predictors of future adherence. Strategies such as cognitive behavioral therapy or motivational enhancement can improve adherence, especially during the initial period. Long-term adherence can be predicted by the initial one and maintained with scheduled follow-up. Group meetings, telephone calls and telemedicine interactions are also a valid way of improving adherence. Conclusions: A Patients should initially be educated about how their symptoms are related to sleep apnoea and how CPAP treatment could resolve them. The key to improving CPAP adherence is to involve patients in personalised treatment with scheduled follow-up, particularly during the initial treatment period.

  • Open Access

    The Impact of Lung Function on Sleep Monitoring in Obstructive Sleep Apnea Associated with Obstructive Lung Diseases: Insights from a Clinical Study

    by Antonio Fabozzi, Alessia Steffanina, Ambra Nicolai, Federica Olmati, Matteo Bonini, Paolo Palange

    Background/Objectives: Obstructive sleep apnea (OSA) and obstructive lung diseases (OLD) are common and interdependent respiratory disorders, where one condition may contribute to the development and worsening of the other (OLDOSA syndrome). The term OLDOSA syndrome includes two different conditions: Overlap syndrome (OVS: OSA + chronic obstructive pulmonary disease, COPD) and Alternative Overlap syndrome (aOVS: OSA + Asthma). Data on the interactions between lung function and respiratory monitoring during sleep in OLDOSA patients are few and controversial. Our study aims to evaluate the impact of lung function impairment on sleep breathing disorders, paying attention to the lack of literature about comparisons between OVS, aOVS, and the impact of small airways disease (SAD) in these patients. Methods: In total, 101 patients with a diagnosis of OSA and asthma or COPD underwent pulmonary function tests (PFTs) and nocturnal home sleep cardiorespiratory monitoring (HSCM). Exclusion criteria: Obesity hypoventilation syndrome (OHS) and other non-respiratory sleep disorders. Results: Sleep time with oxygen saturation below 90% (T90) was negatively correlated with forced expiratory volume in the first second, % of predicted (%FEV1), forced vital capacity, % of predicted (%FVC), forced expiratory flow at 25–75% of the pulmonary volume, % of predicted (%FEF25–75), and, after multivariable linear regression analysis, %FEF25–75 remained an independent factor for T90 with a negative correlation in mild and moderate OSA. Obstructive apnea index (oAI) and FEV1/FVC were negatively correlated in mild and moderate OSA. OVS presented with more severe OSA (higher AHI, oAI, and T90) and SAD (lower FEF25–75) compared to aOVS. Conclusions: This study highlights a possible interdependence between OLD and OSA; obstruction of the large and small airways at PFTs contributes to the worsening of these patients’ nocturnal hypoxemia and obstructive events of the upper airway during sleep. Furthermore, this study shows that patients with OVS should be carefully monitored, as they present worse data at HSCM and have greater small airways involvement compared to aOVS.